Just The News

Augmedics launches first-in-human Xvision-spine AR nav system trial

10 hours ago

Surgical VR developer Augmedics said last week it began the first-in-human clinical trial of its Xvision-spine augmented reality surgical navigation center. The trial was launched at at Israel’s Sheba Tel Hashomer Medical Center and Asaf Harofeh Medical Center, led by co-principal investigators Dr. Ran Harel and Dr. Yigal Mirovsky. The Xvision-spine system is an AR surgical navigation […]

The post Augmedics launches first-in-human Xvision-spine AR nav system trial appeared first on MassDevice.

Covalon Tech lands $17m credit facility

11 hours ago

Covalon Technologies said last week it inked a new $17 million banking credit facility with HSBC bank to help fund acquisitions and operations. The new banking agreement includes a $6.8 million (CAD $9 million) acquisition demand line which is repayable over five years, a $3.8 million (CAD $5 million) revolving operating facility and a $2 million […]

The post Covalon Tech lands $17m credit facility appeared first on MassDevice.

Endologix pushes Nellix release timeline to 2021

11 hours ago

Endologix (NSDQ:ELGX) said it doesn’t expect to receive FDA premarket approval for its Nellix 3.5 endovascular sealing system until 2021. The Irvine, Calif.-based company this week updated on its estimated timeline for anticipated FDA approval, saying it expects to land premarket approval for the Nellix stent graft by the first half of 2021. The forecast is […]

The post Endologix pushes Nellix release timeline to 2021 appeared first on MassDevice.

Surgical VR Firm Osso VR Launches Collaborative Training Tool: Exclusive With CEO Dr. Justin Barad

12 hours ago

Osso VR, a leading virtual reality (VR) surgical training technology company, has recently announced the launch of its collaborative training feature that allows multiple surgeons to train together in a single immersive VR space. The option to train collaboratively offers improved learning opportunities for surgeons and the surgical teams regardless of their physical location and […]

UK’s MHRA details what medtech should expect during Brexit

12 hours ago

The UK’s Medicines and Healthcare products Regulatory Agency today released an update on what medtech and pharmaceutical companies can expect to see as the country begins to implement plans to split from the European Union. The Brexit agreement implementation period is set to end on December of 2020, according to the notice, during which the […]

The post UK’s MHRA details what medtech should expect during Brexit appeared first on MassDevice.

Study slams FDA’s ‘fast-track’ approval process

13 hours ago

More than 98% of the 161 foot and ankle implants that were recalled from 2007 through 2017 were approved through the FDA’s 510(k) process, according to a new study. That left one recalled device approved via the more stringent premarket approval (PMA) process and two for which the submission procedure was not indicated. The 510(k) process allows […]

The post Study slams FDA’s ‘fast-track’ approval process appeared first on MassDevice.

FDA approves Ivantis’ Hydrus microstent

14 hours ago

Ivantis said today it won FDA approval for its Hydrus microstent designed to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. The Hydrus microstent is designed for minimally invasive microsurgical procedures to reduce eye pressure in patients with glaucoma. The device is multi-modal, the company said, by creating a large […]

The post FDA approves Ivantis’ Hydrus microstent appeared first on MassDevice.

Hailie Inhaler Monitoring System Now Available Direct to Consumers

15 hours ago

Adherium, a Silicon Valley firm, is releasing its Hailie system for inhaler monitoring in the United States. The company received FDA clearance to sell the product over the counter, allowing patients to work toward improved compliance with regards to their medications. The system includes a sensor that is attached to an inhaler and a smartphone […]

Report: New hack could put malware directly on Medtronic pacers, allow full control

15 hours ago

Vulnerabilities within with Medtronic‘s (NYSE:MDT) pacemakers, its Carelink 2090 pacemaker programmer and associated infrastructure could allow an outside agent to plant malware on the pacers that would allow them to control all shocks delivered by the device, according to a new Wired report. The vulnerabilities were discovered by security firm Whitescope’s Billy Rios and QED […]

The post Report: New hack could put malware directly on Medtronic pacers, allow full control appeared first on MassDevice.

Adherium launches over-the-counter inhaler sensor in US

15 hours ago

Adherium (ASK:ADR) today launched over-the-counter sales of its Hailie digital inhaler add-on in the U.S. The sensor is designed to integrate directly with prescription inhaler medications, sending adherence reminders and relevant data to a user’s smartphone to assist in managing chronic respiratory conditions like asthma and COPD. Get the full story at our sister site, Drug […]

The post Adherium launches over-the-counter inhaler sensor in US appeared first on MassDevice.

SpaceLabs’ Arkon anesthesia system recalled again

16 hours ago

The FDA  has slapped SpaceLabs Healthcare with a Class 1 recall of its Arkon anesthesia delivery system for going into a “failed state” on numerous occasions since 2013. The recall covers 253 units. No injuries or deaths were reported. During the failed state, the mechanical ventilation function stops working while the machine is in use […]

The post SpaceLabs’ Arkon anesthesia system recalled again appeared first on MassDevice.

Hospital Introducing HoloLens Augmented Reality into the Operating Room

16 hours ago

Alder Hey, an important children’s hospital in Liverpool, England, is working on integrating Microsoft HoloLens augmented reality technology into its operating theaters. The HoloLens is a headset that is able to overlay digital images onto a person’s field of view, essentially mixing virtual reality with the real world. The hospital partnered with Black Marble, a Microsoft partner […]

Hologic pulls Vitalia handpieces, probes in light of FDA concerns over vaginal rejuv tech

16 hours ago

Hologic (NSDQ:HOLX) said today that its subsidiary Cynosure is suspending marketing and distribution of its TempSure Vitalia handpieces and probes after the FDA released a warning about a lack of evidence to support certain “vaginal rejuvenation” products late last month. The Marlborough, Mass.-based company said that it takes “the FDA’s recent statements very seriously” and […]

The post Hologic pulls Vitalia handpieces, probes in light of FDA concerns over vaginal rejuv tech appeared first on MassDevice.

3D Printed Silicone and Stem Cell Implant to Treat Spinal Cord Injuries

16 hours ago

Spinal cord injuries are notorious for the disabilities they cause and for the difficulty of finding a way to fix them. At the University of Minnesota researchers are pointing to a potential solution in the form of 3D printed scaffolds seeded with neuronal stem cells. The team has already created a prototype device, made of […]

Artificial Intelligence Optimizes Chemo and Radiotherapy to Treat Glioblastomas

16 hours ago

Patients with glioblastoma, a persistent and difficult to treat brain cancer, often end up suffering through multiple rounds of chemo and radiation therapy. Scientists at MIT have been working on harnessing the power of artificial intelligence to better optimize the therapy dosages, sparing the patients the brunt of the treatments while maintaining their clinical effectiveness. […]

GI Dynamics wins FDA nod for pivotal US EndoBarrier trial

17 hours ago

GI Dynamics (ASX:GID) said today it won FDA investigational device exemption approval to launch a pivotal trial of its EndoBarrier device designed for treating patients with type 2 diabetes and obesity, pending Institutional Review Board approval. The EndoBarrier device is a plastic gut sleeve designed to prevent the absorption of nutrients from food as it exits the stomach and […]

The post GI Dynamics wins FDA nod for pivotal US EndoBarrier trial appeared first on MassDevice.

Inside Hologic’s evolving definition of women’s healthcare

18 hours ago

Hologic (NSDQ:HOLX), known in the medtech industry for its mammography and diagnostics devices, is rethinking what it means to be a women’s healthcare company. The 6,000-person company wants to expand its reach to include products that care for women’s well-being, as well as their health – a concept that Dr. Edward Evantash honed when he led […]

The post Inside Hologic’s evolving definition of women’s healthcare appeared first on MassDevice.

J&J loses early bid to escape Pfizer's Remicade biosimilars lawsuit

19 hours ago

Johnson & Johnson has to face Pfizer's Remicade antitrust accusations, a judge ruled Friday, allowing a high-profile lawsuit to move forward. Pfizer claims J&J struck payer deals designed to freeze out Remicade biosimilars, including its own Inflectra.

J&J’s Cerenovus wins CE Mark for Bravo flow diverter

3 days ago

Johnson & Johnson‘s (NYSE:JNJ) Cerenovus said this week it won CE Mark approval in the European Union for its Bravo flow diverter designed to treat intracranial aneurysms. The newly cleared device is designed to divert blood flow from aneurysms to promote healing and reduce the risk of rupture, the company said. The Bravo is Cerenovus’ first flow […]

The post J&J’s Cerenovus wins CE Mark for Bravo flow diverter appeared first on MassDevice.

NuCryo Vascular inks PolarCath distro deal with Lokai Medical

3 days ago

Privately held cryoplasty developer NuCryo Vascular said today it inked a deal with Lokai Medical to distribute its PolarCath balloon dilation system in the US. San Jose, Calif.-based NuCryo Vascular’s PolarCath system is designed to be used in Balloon Cryoplasty procedures to treat peripheral artery disease. The system has FDA approval and is cleared to […]

The post NuCryo Vascular inks PolarCath distro deal with Lokai Medical appeared first on MassDevice.

Endologix shares plunge on Q2 earnings miss

4 days ago

Shares in Endologix (NSDQ:ELGX) have lost nearly 40% after the company released second quarter earnings that missed loss per share expectations on Wall Street and lowered its guidance for the full year. The Irvine, Calif.-based company posted losses of $23.9 million, or 28¢ per share, on sales of $44.7 million for the three months ended June 30, […]

The post Endologix shares plunge on Q2 earnings miss appeared first on MassDevice.

Shift Labs Announces Partnership with Option Care Enterprises for National Use of DripAssist

4 days ago

DripAssist by Shift Labs is an infusion rate monitor that offers a significant improvement in portability, efficiency, durability and ease of use over traditional infusion monitors. The last time Medgadget reported on Shift Labs, the company had just received their CE mark for DripAssist. The device is also FDA approved. Now, Shift Labs is announcing a […]

Highly Sensitive Electronic Skin Detects Touch and Temperature Changes

4 days ago

The University of Texas at Arlington has obtained a patent for a highly sensitive electronic skin that may one day give prosthetic devices a keen sense of touch. The e-skin features a dense forest of flexible zinc oxide nanowires on its surface. As it comes in contact with something, each nanowire generates a small electric […]

First Patient Receives Medtronic’s Extravascular Implantable Cardioverter Defibrillator

4 days ago

A pilot study is getting underway to evaluate a new Medtronic implantable cardioverter defibrillator that doesn’t require leads to be placed inside the heart or veins. The Extravascular Implantable Cardioverter Defibrillator (EV ICD) system can deliver defibrillation shocks as well as pacing signals to the heart, but it uses only a single lead placed under the […]

ElectroCore inks nVNS neuroinflammatory response research deal with MGH

4 days ago

ElectroCore said yesterday it inked a collaborative research deal with Massachusetts General Hospital exploring the use of ElectroCore’s non-invasive vagus nerve stimulation tech in targeted treatments for neuroinflammation. The Basking Ridge, N.J.-based company said that investigators will examine the effects the nVNS system has on neuroinflammatory mechanisms associated with conditions in the central nervous system including […]

The post ElectroCore inks nVNS neuroinflammatory response research deal with MGH appeared first on MassDevice.

NuVasive, Siemens ink spinal surgery joint dev deal

4 days ago

NuVasive (NSDQ:NUVA) said yesterday it inked a strategic partnership deal with Siemens (NYSE:SI) Healthineers looking to develop and advance technology designed for minimally invasive spinal surgery. Through the deal, dubbed the Spine Precision Partnership, the companies will look to jointly advance their proprietary technologies, looking to improve operating room workflow efficiency and the delivery of minimally disruptive spinal […]

The post NuVasive, Siemens ink spinal surgery joint dev deal appeared first on MassDevice.

Plaintiffs in J&J DePuy Ortho Pinnacle hip bellwether seek $246m in damages

4 days ago

A group of plaintiffs who sued Johnson & Johnson‘s (NYSE:JNJ) DePuy Orthopaedics in a bellwether case over alleged defects associated with its Pinnacle metal-on-metal hips are looking for approximately $246.1 million in damages, according to recently released court documents. The damages come after a jury in Texas federal court ruled in favor of the plaintiffs, […]

The post Plaintiffs in J&J DePuy Ortho Pinnacle hip bellwether seek $246m in damages appeared first on MassDevice.

How Insulet’s CEO plans to create a billion-dollar business

4 days ago

When Pat Sullivan joined Insulet (NSDQ:PODD) in 2014, the Billerica, Mass.-based company was reeling in roughly $300 million in revenue selling its Omnipod tubless insulin delivery system. Sullivan, a veteran of the medtech industry, saw a path to creating a billion-dollar company and it centered around the concept of making life easier for people with diabetes. “I […]

The post How Insulet’s CEO plans to create a billion-dollar business appeared first on MassDevice.

AngioDynamics nets a win in antitrust case against BD’s Bard

4 days ago

A federal judge in New York this week denied a motion from Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard to dismiss an antitrust lawsuit filed by AngioDynamics (NSDQ:ANGO) alleging unfair competition, according to an Albany Business Review report. AngioDynamics filed the suit against Bard last May, claiming that the larger company illegally ties the sales of its […]

The post AngioDynamics nets a win in antitrust case against BD’s Bard appeared first on MassDevice.

Medtronic launches Extravascular ICD pilot study

4 days ago

Medtronic (NYSE:MDT) said yesterday it launched a pilot study of its investigational Extravascular Implantable cardioverter defibrillator system, with the first patient implant already performed at New Zealand’s Christchurch Hospital. The Fridley, Minn.-based company’s EV ICD system uses leads placed outside of the heart and veins to provide both defibrillation and antitachycardia pacing therapy. The initial implantation […]

The post Medtronic launches Extravascular ICD pilot study appeared first on MassDevice.

Artios bags $84M to trial next-generation DNA damage response drugs

4 days ago

Artios Pharma has raised $84 million (£65 million) to take DNA damage response (DDR) programs to clinical proof of concept. The series B round sees more big-name investors give cash to researchers whose earlier work on PARP inhibitor Lynparza put DDR on the map.

Artios bags $84M to trial next-generation DNA damage response drugs

4 days ago

Artios Pharma has raised $84 million (£65 million) to take DNA damage response (DDR) programs to clinical proof of concept. The series B round sees more big-name investors give cash to researchers whose earlier work on PARP inhibitor Lynparza put DDR on the map.

Could a glaucoma drug also fight obesity?

4 days ago

Scientists have examined many ways to “beige” unhealthy white fat into energy-burning brown fat to reduce obesity. Now researchers at Yale University believe they’ve found a target for preventing fat from entering body tissues in the first place, and a class of eye drugs that could help.

Could a glaucoma drug also fight obesity?

4 days ago

Scientists have examined many ways to “beige” unhealthy white fat into energy-burning brown fat to reduce obesity. Now researchers at Yale University believe they’ve found a target for preventing fat from entering body tissues in the first place, and a class of eye drugs that could help.

Genotype-Specific Microparticle Treatment for Brain Cancer

4 days ago

Researchers from Harvard and MIT have developed microparticles that can treat a specific genetic subtype of glioma, a brain cancer. The microparticles slowly release a drug that specifically targets cancer cells that rely on a particular enzyme. During surgery to remove the brain tumor, clinicians can conduct a rapid (30 min) genetic test on a […]

New Device for Testing Immunotherapies on Tumor Fragments

4 days ago

Immuno-oncology, a rapidly developing field that harnesses the body’s immune system to attack cancers, lacks effective methods of testing potential therapies. In addition to animal studies, tiny bits of tumors are placed, along with chemical compounds being tested, within multiwell plates and watched over using a number of techniques. While this has allowed the field […]

Orthofix Q2 shows shrinking profits

4 days ago

Orthofix (NSDQ:OFIX) this week posted second quarter earnings that beat expectations on Wall Street but showed growing losses. The Lewisville, Texas-based company posted profits of $925,000, or 5¢ per share, on sales of $111.6 million for the three months ended June 30, seeing profits shrink 97.6% while sales grew 2.4% compared with the same period last […]

The post Orthofix Q2 shows shrinking profits appeared first on MassDevice.

Report: ICS-CERT tags 2 Medtronic devices with cybersecurity vulnerabilities

4 days ago

The US Dept. of Homeland Security’s Industrial Control Systems Computer Emergency Response Team this week flagged two Medtronic (NYSE:MDT) devices for cybersecurity vulnerabilities that could allow attackers to obtain sensitive information, according to a HealthITSecurity report. The Fridley, Minn.-based medtech giant’s MyCareLink patient monitor and MiniMed Paradigm insulin pump and remote controller were specifically identified by the […]

The post Report: ICS-CERT tags 2 Medtronic devices with cybersecurity vulnerabilities appeared first on MassDevice.

Hancock Jaffe steps closer to launching Colombian VenoValve trial

5 days ago

Hancock Jaffe Laboratories (NSDQ:HJLI) said today it won approval from Colombia’s Medical Research Committee at Fundación Santa Fe de Bogotá to launch a first-in-human trial of its VenoValve bioprosthetic valve. The Irvine, Calif.-based company’s VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from […]

The post Hancock Jaffe steps closer to launching Colombian VenoValve trial appeared first on MassDevice.

Medtronic launches engagement program for diabetes patients

5 days ago

Medtronic (NYSE:MDT) said today that it launched its Inner Circle patient engagement program in the U.S. The medtech titan’s program, which is designed for people living with diabetes, uses gamification to motivate and encourage its users to practice behaviors that help them control their blood sugar levels. Get the full story at our sister site, Drug Delivery […]

The post Medtronic launches engagement program for diabetes patients appeared first on MassDevice.

PARP inhibitors show promise for treating ALS and other brain disorders

5 days ago

PARP inhibitors prevent the misplacement of a specific protein that has been implicated in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, Penn researchers have discovered. They believe the drugs, currently approved to treat ovarian cancer, could be fine-tuned for use in brain disorders.

PARP inhibitors show promise for treating ALS and other brain disorders

5 days ago

PARP inhibitors prevent the misplacement of a specific protein that has been implicated in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, Penn researchers have discovered. They believe the drugs, currently approved to treat ovarian cancer, could be fine-tuned for use in brain disorders.

Caretaker Beat-by-Beat Continuous Blood Pressure and Vital Signs Monitor Cleared in EU

5 days ago

Caretaker Medical, a firm based in Charlottesville, Virginia, won approval to introduce its Caretaker 4 wireless continuous non-invasive blood pressure (CNIBP) and vital signs monitoring system in the European Union. The product, already approved in the U.S., provides beat-by-beat blood pressure measurements with an accuracy sufficient for intensive care units. It also keeps track of the heart […]

Medtronic Begins Pilot Study of Investigational Extravascular ICD System

5 days ago

Medtronic plc (NYSE:MDT) today announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and antitachycardia pacing therapy all in one system, with a device size similar to transvenous ICDs.

Struggling Perrigo OKs plan to hive off prescription business

5 days ago

It was nearly two years ago that activist investors began urging Perrigo to hive off its specialty pharma unit. Now, it’s finally happening. The Dublin drugmaker said Thursday that its board had OK’d a plan to split off the company’s prescription drugs business.

Novo powers rare disease startup Therachon to $60M round

5 days ago

Therachon has raised $60 million (€52 million) to take a phase 1 rare disease drug deeper into the clinic. The Novo Holdings-led mezzanine round comes six months after Therachon began testing its FGFR3 ligand trap in healthy volunteers.

Novo powers rare disease startup Therachon to $60M round

5 days ago

Therachon has raised $60 million (€52 million) to take a phase 1 rare disease drug deeper into the clinic. The Novo Holdings-led mezzanine round comes six months after Therachon began testing its FGFR3 ligand trap in healthy volunteers.

Congressman charged in biotech insider trading case

5 days ago

Republican Congressman Chris Collins has been charged with securities fraud. The case relates to a failed multiple sclerosis trial that precipitated a 92% drop in the stock price of Australian biotech Innate Immunotherapeutics.

Congressman charged in biotech insider trading case

5 days ago

Republican Congressman Chris Collins has been charged with securities fraud. The case relates to a failed multiple sclerosis trial that precipitated a 92% drop in the stock price of Australian biotech Innate Immunotherapeutics.

TransEnterix Earnings SWOT Analysis

6 days ago

Our goal with this post is to breakdown the earnings report and conference call with a SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis. By breaking down the business, we can better determine how the company is performing compared to their goals.

How virus 'clusters' cause norovirus and other stomach bugs to spread

6 days ago

A team led by researchers at the National Institute of Health have discovered that stomach illnesses including norovirus, famous for wreaking havoc on cruise ships, get transmitted to humans through "virus clusters" that exacerbate the spread and severity of symptoms.

How virus 'clusters' cause norovirus and other stomach bugs to spread

6 days ago

A team led by researchers at the National Institute of Health have discovered that stomach illnesses including norovirus, famous for wreaking havoc on cruise ships, get transmitted to humans through "virus clusters" that exacerbate the spread and severity of symptoms.

Cardinal Health Earnings Highlights

7 days ago

Cardinal Health's stock continues to rise after reporting better than expected Q4 earnings yesterday, beating on both profit and revenue.

FDA notes Paratek antibiotic’s noninferiority as it heads to AdComm vote

7 days ago

Paratek Pharmaceuticals’ first drug, and the first in a new class of broad-spectrum antibiotics called aminomethylcyclines, has shown to be noninferior to current regimens for bacterial pneumonia and skin infections, FDA reviewers wrote ahead of an Aug. 8 advisory committee meeting.

FDA notes Paratek antibiotic’s noninferiority as it heads to AdComm vote

7 days ago

Paratek Pharmaceuticals’ first drug, and the first in a new class of broad-spectrum antibiotics called aminomethylcyclines, has shown to be noninferior to current regimens for bacterial pneumonia and skin infections, FDA reviewers wrote ahead of an Aug. 8 advisory committee meeting.

Akouos raises $50M to take hearing loss gene therapy into humans

7 days ago

Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside the appointment of a Spark Therapeutics co-founder and other organizational changes.

Akouos raises $50M to take hearing loss gene therapy into humans

7 days ago

Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based biotech unveiled the series A round alongside the appointment of a Spark Therapeutics co-founder and other organizational changes.

U.K. commits to adopt EU trial regulation, minimize divergence after Brexit

7 days ago

The U.K. regulatory agency has detailed how it expects Brexit to affect its clinical trial regulations. Officials reiterated their intent for the U.K. to implement the incoming European Union Clinical Trials Regulation and expanded on the long-term effects of Brexit on research approval processes.

U.K. commits to adopt EU trial regulation, minimize divergence after Brexit

7 days ago

The U.K. regulatory agency has detailed how it expects Brexit to affect its clinical trial regulations. Officials reiterated their intent for the U.K. to implement the incoming European Union Clinical Trials Regulation and expanded on the long-term effects of Brexit on research approval processes.

Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer

1 week ago

The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but only one inherited mutation—in the gene BRCA1—has been definitively linked to this subtype of the disease. Now researchers at the Mayo Clinic have discovered four additional gene alterations that are associated with an elevated risk.

Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer

1 week ago

The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but only one inherited mutation—in the gene BRCA1—has been definitively linked to this subtype of the disease. Now researchers at the Mayo Clinic have discovered four additional gene alterations that are associated with an elevated risk.

Regeneron, Bluebird ink anti-cancer cell therapy pact

1 week ago

Regeneron and Bluebird bio have teamed up to develop anti-cancer cell therapies. The collaboration combines Regeneron’s antibody expertise with Bluebird’s cell therapy toolkit in a bid to expand the list of tumors modified T cells can treat.

Regeneron, Bluebird ink anti-cancer cell therapy pact

1 week ago

Regeneron and Bluebird bio have teamed up to develop anti-cancer cell therapies. The collaboration combines Regeneron’s antibody expertise with Bluebird’s cell therapy toolkit in a bid to expand the list of tumors modified T cells can treat.

Mazor Robotics Misses on Revenue But System Sales Remain Strong

1 week ago

Mazor Robotics ($MZOR) shares have been under significant pressure after reporting a disappointing Q2 earnings report this past Thursday. At Wednesday's close, Mazor Robotics was trading at $63.43 and is currently trading at $52.00 on Friday afternoon.

NuVasive Q2 Earnings Highlights

2 weeks ago

“We are pleased with our second quarter total revenue growth of 8.5% year‐over‐year driven by momentum in our U.S. Spinal Hardware business where we saw spine case volumes up nearly 7% versus prior year,” said Gregory T. Lucier, chairman and chief executive officer of NuVasive.

Become a Medtechy Contributor

2 weeks ago

Medtechy started out as a site with forums for companies in the medical device and pharmaceutical industries into a platform with the most up-to-date news in healthcare and a full blown recruiting platform with ZipRecruiter integration for all of our paid job postings.

Smith & Nephew Q2 Earnings Breakdown

3 weeks ago

Smith & Nephew released positive Q2 earnings this morning, helping the stock jump over 2% during Thursday's trading session. Part of the increase was due to the confirmed guidance for the year, which is expected to be in the 2-3% growth range.

House Passes Medical Device Tax Repeal. On to the Senate

3 weeks ago

Yesterday the House voted to permanently repeal the 2.3% medical device tax, which was included in the Affordable Care Act in 2010 as a tax that many felt curbed medical innovation. The measure was approved on a 283-132 vote.

Nevro Announces Patent Litigation Update

3 weeks ago

​It's been a whirlwind 24 hours for Nevro's stock as yesterday afternoon, rumors started floating on Twitter that Nevro had lost their patent dispute with Boston Scientific, bringing Nevro's stock down 39% at one point.

AngioDynamics Agrees to Pay $12.5 Million to Resolve False Claims Act Allegations

4 weeks ago

According to the Justice Department, medical device manufacturer AngioDynamics, has agreed to pay the United States a total of $12.5 million to resolve allegations that the company caused healthcare providers to submit false claims to Medicare, Medicaid, and other federal healthcare programs relating to the use of two medical devices, LC Bead and the Perforator Vein Ablation Kit (PVAK).

Abbott CEO gives a great lesson in accountability

4 weeks ago

​During Abbott's most recent earnings call​, an analysts asked a question about Abbott's neuromod performance and Abbott CEO, Miles White, gave an absolutely brilliant lesson in accountability.

Abbott's Medical Device Business is Rolling

4 weeks ago

Abbott ($ABT) announced another solid quarter yesterday, with all of their business segments exceeding expectations. As noted by WSJ reporter, Charley Grant, the performance is becoming like clockwork for Miles White and team.

Diabetes is a main ingredient in Medtronic's Value Based Healthcare Program

4 weeks ago

There's been much talk on our forums about Medtronic's value based healthcare initiative and how the program brings value to Medtronic and the healthcare system as a whole. Just last week, Medtronic and UnitedHealthcare announced successful data showing the benefits of using Medtronic's MiniMed 670G system to help mitigate hospital costs.

Nevro fires sales VP. Stock down over 17%

1 month ago

Nevro disclosed​ that they recently terminated their sales VP, Jim Alexih, after only being on the job approximately 8 months. There was no news if Nevro has hired a replacement.

Medtronic and UnitedHealthcare Release Successful Value-Based Healthcare Data

1 month ago

Medtronic's value-based healthcare initiative has been a consistent conversation on our forums with community members trying to understand the specifics of the program and its benefit to the healthcare system as a whole. Some of the confusion was cleared up today as Medtronic and UnitedHealthcare announced first year results from their value-based relationship, which is focused on delivering patient-centered solutions that improve health outcomes while reducing soaring healthcare costs related to managing diabetes.

FDA Approves the Pulmonx Zephyr Valve for Emphysema Patients

1 month ago

In late June, the FDA approved the Zephyr Endobronchial Valve System, which is the first minimally-invasive device approved in the United States for treating patients with severe emphysema, a progressive and life-threatening form of chronic obstructive pulmonary disease (COPD).

Novartis to spin off Alcon and launch a $5 billion share buyback

1 month ago

Novartis (NYSE:NVS) is back to focusing on being a drug company as they've decided to spin off Alcon and launch a $5 billion share buyback. This announcement comes after years of speculation that Novartis would part ways with Alcon and investors welcomed the news with the stock up ~4% in early trading.

First medicine made from marijuana receives FDA approval

2 months ago

The FDA announced that they have approved GW Pharmaceuticals’ Epidiolex, a drug designed to treat two rare forms of childhood epilepsy using a cannabis compound called cannabidiol (or CBD). Epidiolex becomes the first prescription pharmaceutical formulation of highly-purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the high associated with marijuana, and the first in a new category of anti-epileptic drugs (AEDs).

Surgeon calls out Abbott on Twitter over St. Jude ICDs

2 months ago

The way surgeons and medical device companies interact has officially been turned upside down. Who's the culprit? Twitter. No longer can a surgeon share a concern to their local sales rep and then rely on that rep to take their grievances up the corporate food chain.

What do medical sales reps make in 2018?

2 months ago

MedReps recently released their eighth annual medical sales salary report and the information for prospective medical sales representatives continues to be invaluable. You can find the original report here.

NuVasive Launches AttraX Scaffold Biologic

2 months ago

NuVasive (NASDAQ: NUVA) announced the U.S. launch of AttraX® Scaffold, an absorbent ceramic-collagen bone graft with an optimized surface that has been validated in preclinical testing to drive increased bone formation and faster fusion than traditional ceramic bone grafts.

6 Recent Stories of Healthcare Fraud

2 months ago

We've rounded up some of the latest stories involving fraud in healthcare. If you have any information of fraud going on at your company or hospital, submit a tip through our anonymous tip line.

Envision Healthcare to be Acquired by KKR for $9.9 billion

2 months ago

Envision Healthcare Corporation (NYSE: EVHC) today announced it has entered into a definitive agreement to be acquired by global investment firm KKR in an all-cash transaction for approximately $9.9 billion, including the assumption or repayment of debt.

Do You Want to Be a Great Leader? Start With These 5 Books

2 months ago

As sales managers, continuously adapting and testing new ideas while sticking to a process are some of the main challenges in leading a team of people with a variety of skill sets. There is no one stop shop in management skills and we've found the best way to succeed is by talking to other successful leaders and reading quality books for inspiration.

Fortive Acquires JNJ's ASP for $2.7B

2 months ago

The rumors have been out there for months that Johnson & Johnson was looking to offload Advanced Sterilization Products (ASP), and today, they went ahead and announced a deal to sell the company for Fortive Corporation for $2.7B.

Medtronic Investor Day Broken Down

2 months ago

There was mixed reaction to Medtronic's Investor Day with the stock falling 1% after their presentation, but was also met with some bullish sentiment from Jim Cramer. In addition to highlighting Medtronic's future technology, Medtronic CEO, Omar Ishrak, provided specific goals and outlined the company's long-range financial targets, with its primary focus on driving operating leverage and improving its free cash flow conversion. Specifically, to drive sustainable growth and return, the company is providing the following long-range targets:

Apple opens Health Records API to developers

2 months ago

Apple packed a ton of exciting updates into their WWDC keynote yesterday but health care updates were light compared to past events. The lack of splash at WWDC doesn't mean Apple isn't focused on healthcare going forward. In fact, in lieu of making a big announcement during the keynote, the company posted an interesting update on its website.

Fitbit Making a Comeback with Versa

2 months ago

Fitbit's stock jumped over 6% today after announcing that they have shipped more than one million Fitbit Versa™ devices since the device went on sale. This success is welcome news for a company who's seen its stock fall 70% since going public in 2015 and failing with their first smart-watch, the Ionic.

Intuitive Surgical Ready to Launch SP

2 months ago

Initially cleared for urological procedures in 2014, Intuitive Surgical announced today that they received a new indication for its da Vinci SP surgical system. The new indication will cover procedures requiring very narrow access from a single small incision.

Medical Device Recalls Highest Since 2005

2 months ago

A new report showed that there were more medical devices recalled in the first quarter of 2018 than at any time since 2005. The same report also showed that prescription drugs recalls increased.

You're Not Steve Jobs so Stop Trying to Manage like Him

2 months ago

We recently wrote about, "Bad Blood," the fantastic book by John Carreyrou that exposes the greed and deception by Elizabeth Holmes at Theranos. Aside from learning about the inner-workings of the company, the book highlighted Elizabeth Holmes leadership style. Calling it her style is a bit of a lie because, reportedly, she copied Steve Jobs and tried to emulate everything about him, all the way down to copying the black turtlenecks Jobs wore.

Intuitive Surgical Going Direct in India

2 months ago

For the last seven years, Intuitive Surgical has been working with Vattikuti Technologies Pvt. Ltd. as their distributor in India. Today, the company announced they are going direct in the country, with more than 60 former Vattikuti employees becoming a part of Intuitive India’s business.

Transenterix is Clicking on All Cylinders

3 months ago

TransEnterix CEO, Todd Pope, set forth very specific goals for 2018 and the company has started the year consistently achieving these goals. Earlier in the month, TransEnterix, announced positive Q1 results and now the company has announced that they received FDA 510(k) clearance of expanded indications for their Senhance Surgical System.

'Bad Blood' Highlights Greed and Deception at Theranos

3 months ago

The story of Theranos is so mind-blowing that you are left wondering how it even happened. For example, how did Theranos raise $1.37B in 10 rounds of financing without having a product that did what they promised it would do?

Avinger Stock Rockets Higher After Receiving FDA Clearance for Next-Generation Pantheris

3 months ago

Avinger (NASDAQ: AVGR) received welcome news today as they received received 510(k) clearance from the FDA for its next generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease. As we recently wrote, the success of the next generation Pantheris will play a crucial part in Avinger's turnaround plan.

Migraine Drug Could Add 10% to Amgen's Revenue

3 months ago

On CNBC's "Power Lunch," a Wall Street analyst stated that Amgen's recently approved migraine drug, Aimovig, could become a $2 billion business in the next five years. That revenue would equate to a 10 percent increase to Amgen's revenue as the drug provides a huge unmet need for adults who deal with migraines.

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a